KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $44.2 million.

  • Idexx Laboratories' Net Cash Flow rose 144.94% to $44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.9 million, marking a year-over-year decrease of 264.52%. This contributed to the annual value of -$156.1 million for FY2024, which is 146.02% down from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Net Cash Flow is $44.2 million, which was up 426.72% from -$13.5 million recorded in Q2 2025.
  • Idexx Laboratories' Net Cash Flow's 5-year high stood at $201.6 million during Q3 2023, with a 5-year trough of -$122.0 million in Q1 2025.
  • Over the past 3 years, Idexx Laboratories' median Net Cash Flow value was -$1.7 million (recorded in 2023), while the average stood at $8.3 million.
  • As far as peak fluctuations go, Idexx Laboratories' Net Cash Flow spiked by 7,091.35% in 2022, and later crashed by 3,021.01% in 2024.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Net Cash Flow stood at $104,000 in 2021, then surged by 7,091.35% to $7.5 million in 2022, then soared by 1,472.03% to $117.6 million in 2023, then tumbled by 109.02% to -$10.6 million in 2024, then spiked by 144.94% to $44.2 million in 2025.
  • Its last three reported values are $44.2 million in Q3 2025, -$13.5 million for Q2 2025, and -$122.0 million during Q1 2025.